The observed reduction in the level of free Keap1 in the granulocytes of patients who died from COVID-19 was associated with a significant increase in Nrf2 levels, which, in turn, promotes increased transcriptional activity of Nrf2 manifested in increased HO-1 levels. This evidence concerns the gene KEAP1 and COVID-19.